Showing results (131-140 of 240) with videos related to
Sort By:
Pageof 24
JCO Oncology Practice|July 2, 2020
Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern ChemoradiationRamez Kouzy, Joseph Abi Jaoude, Daniel Lin, et al.Diseases of the Colon and Rectum|May 4, 2005
The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancerLarissa K Temple, Jennifer Bacik, Salvatore G Savatta, et al.Clinical and Translational Radiation Oncology|May 5, 2022
Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancerShalini Moningi, Xiudong Lei, Penny Fang, et al.Advances in Radiation Oncology|October 30, 2018
Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiationGarrett Jensen, Randa Tao, Cathy Eng, et al.Diseases of the Colon and Rectum|January 9, 2008
Squamous-cell carcinoma of the anal canal: predictors of treatment outcomeRamin Roohipour, Sujata Patil, Karyn A Goodman, et al.Cancers|January 11, 2024
Patient-Reported Sexual Function, Bladder Function and Quality of Life for Patients with Low Rectal Cancers with or without a Permanent OstomyMichael K Rooney, Melisa Pasli, George J Chang, et al.The American Journal of Surgical Pathology|July 20, 2002
Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapyJinru Shia, Satish K Tickoo, Jose G Guillem, et al.The Oncologist|September 5, 2020
Professional Medical Writer Assistance in Oncology Clinical TrialsRamez Kouzy, Joseph Abi Jaoude, Walker Mainwaring, et al.Diseases of the Colon and Rectum|July 31, 2007
Squamous-cell carcinoma of the rectum: a rare but curable tumorCaio S R Nahas, Jinru Shia, Romane Joseph, et al.Advances in Radiation Oncology|March 29, 2024
Long-Term Patient-Reported Dyspareunia After Definitive Chemoradiation for Anal Cancer: Using the Anterior Vaginal Wall as an Organ-at-Risk to Define an Actionable Dosimetric GoalMichael K Rooney, Joshua S Niedzielski, Ramon M Salazar, et al.Pageof 24